Robert Ornelas, MD
Psychiatry · West Columbia, SCNPI 1497860159
Payments from drug & device makers
Across 647 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$2K
- Otsuka America Pharmaceutical, Inc.$2K
- AbbVie$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Teva Pharmaceuticals USA, Inc.$840
- Sunovion Pharmaceuticals Inc.$785
- plus $4K from 22 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 82 | $1,740 |
| Otsuka America Pharmaceutical, Inc. | 67 | $1,551 |
| AbbVie(2 entities) | 132 | $1,523 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 53 | $1,237 |
| Teva Pharmaceuticals USA, Inc. | 45 | $840 |
| Sunovion Pharmaceuticals Inc. | 44 | $785 |
| Johnson & Johnson | 23 | $660 |
| Alkermes, Inc. | 28 | $556 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $497 |
| Bausch Health US, LLC | 20 | $364 |
| Vanda Pharmaceuticals Inc. | 17 | $363 |
| Lundbeck LLC | 22 | $360 |
| Almatica Pharma LLC | 15 | $224 |
| Supernus Pharmaceuticals, Inc. | 9 | $220 |
| Merck | 13 | $202 |
| Avanir Pharmaceuticals, Inc. | 11 | $175 |
| E.r. Squibb & Sons, L.L.C. | 2 | $151 |
| Axsome Therapeutics, Inc. | 7 | $141 |
| Acadia Pharmaceuticals Inc | 5 | $111 |
| Eisai Inc. | 7 | $106 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $89 |
| Idorsia Pharmaceuticals US Inc | 3 | $54 |
| Jazz Pharmaceuticals Inc. | 3 | $52 |
| Adlon Therapeutics L.p. | 3 | $36 |
| Noven Therapeutics, LLC | 2 | $30 |
| Alfasigma USA, Inc. | 2 | $27 |
| Tris Pharma Inc | 1 | $17 |
| Neos Therapeutics, LP | 1 | $14 |
How this compares
$12,125 in reported general payments places this provider in the 90th percentile of 624 psychiatry providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in West Columbia
- John SteeleWest Columbia$9K
- Jacobo MintzerCharleston$4.9M
- Paul RobbinsSummerville$1.2M
- Brittany AlbrightMount Pleasant$691K
- Eduardo CifuentesCharleston$675K
- Veronica RidpathFlorence$364K
- Mark GeorgeCharleston$332K
- Jagdish ShahRock Hill$320K
- Ricardo FermoCharleston$262K
- John DewittAiken$221K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.